17 May 2018 - People who need expensive PHARMAC funded drugs can access them regardless of their DHB's ability to pay for it under changes to the drug-funding model.
From July 1, PHARMAC will take over responsibility from District Health Boards (DHBs) for buying all their medicines, saving close to $200 million over four years through its purchasing power.
Until now, PHARMAC managed the DHBs' community drug-buying budget while DHBs held their own budget for buying medicines for their hospitals.